Physician profile
Beata Grill
NPI 1407301682
$1,966.00
in general payments reported to CMS, 2019-2025
15 companies · $306 in 2025
The $306 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $728 · 2022: $461 · 2023: $335 · 2024: $135 · 2025: $306.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $777.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $776.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $613.74 | 2021-2025 | Rotapro, Comet, Versacross Access Solution |
| Janssen Pharmaceuticals, INC | $332.91 | 2021-2022 | |
| Abiomed | $215.54 | 2024-2025 | Impella |
| Pfizer INC. | $159.06 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $137.80 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $102.55 | 2021-2022 | |
| Shockwave Medical, INC | $99.72 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Philips North America LLC | $92.94 | 2022 | |
| Medtronic, INC. | $52.97 | 2023 | Corevalve Evolut R |
| Amgen INC. | $38.54 | 2021-2022 | |
| Esperion Therapeutics, INC. | $34.64 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $34.25 | 2021 | |
| Abbott Laboratories | $22.54 | 2021 | |
| Sanofi-Aventis U.S. LLC | $17.36 | 2021 | |
| Chiesi USA, INC. | $11.44 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Beata Grill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.